Deep Track Capital, LP Allakos Inc. Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in Allakos Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 7,232,701 shares of ALLK stock, worth $2.39 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
7,232,701
Previous 5,704,282
26.79%
Holding current value
$2.39 Million
Previous $6.9 Million
75.91%
% of portfolio
0.06%
Previous 0.3%
Shares
8 transactions
Others Institutions Holding ALLK
# of Institutions
67Shares Held
61.7MCall Options Held
71.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA16.6MShares$5.46 Million0.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.69MShares$2.87 Million0.13% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$2.03 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$1.13 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.94MShares$970,1520.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $28M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...